**REGISTERED COMPANY NUMBER: CE017714 (England and Wales) REGISTERED CHARITY NUMBER: 1183723** 

## **REPORT OF THE TRUSTEES AND** 

**UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **FOR** 

## **HEART SUCCESS FOUNDATION** 

Centora James Limited Jury Farm Ripley Lane West Horsley KT24 6JT 



## **HEART SUCCESS FOUNDATION** 

## **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

||**Page**|
|---|---|
|Report of the Trustees|1 to 2|
|Independent Examiner's Report|3|
|Statement of Financial Activities|4|
|Balance Sheet|5|
|Notes to the Financial Statements|6 to 9|
|Detailed Statement of Financial Activities|10|





## **HEART SUCCESS FOUNDATION REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025** 

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). 

## **OBJECTIVES AND ACTIVITIES** 

## **Objectives and aims** 

The Heart Success Foundation ("HSF") exists to advance education, research and collaboration in cardiovascular medicine, for the public benefit, with the aim of improving the prevention and treatment of heart failure and related cardiovascular conditions. 

## **Public benefit** 

The trustees confirm that they have had regard to the Charity Commission's guidance on public benefit in planning and carrying out HSF's activities. By funding educational projects and supporting the professional development of clinicians, HSF helps healthcare professionals access up-to-date knowledge and evidence, which ultimately benefits patients and the wider public through improved standards of cardiovascular care. 

## **ACHIEVEMENT AND PERFORMANCE** 

## **Charitable activities** 

2025 was the Foundation's first full year of grant-funded activity. Following the fundraising work begun in 2024, HSF finalised its first grant agreements and secured grant funding from: 

- Servier Affaires Médicales (€110,000) 

- Institut La Conférence Hippocrate (€90,000) 

- BGP Products Operations GmbH (£30,000) 

- Bruno Farmaceutici (€90,000), a contribution to the OPTIPHARM - IRONCARD Registry on iron deficiency in patients with cardiovascular disease 

Using these funds, HSF awarded its first grants in support of educational projects on mineralocorticoid receptor antagonists (MRAs) in heart failure, including an educational project in Africa. These projects aim to improve clinicians' understanding and use of evidence-based therapies in settings where access to specialist education is limited. 

HSF also supported professional education through the Federation of the Royal Colleges of Physicians of the United Kingdom, and trustees and staff travelled to international meetings to develop partnerships and promote the Foundation's educational work. 

## **FINANCIAL REVIEW** 

## **Financial position** 

Total income for the year was £284,753 (2024: £6,100), almost entirely from grants. Total expenditure was £51,814 (2024: £10,491), including grants awarded of £9,810 and the costs of employing the Foundation's manager. This resulted in net income of £232,939 for the year, and total unrestricted funds of £228,548 at 31 December 2025 (2024: deficit of £4,391). Income included €90,000 (£76,811) due from Bruno Farmaceutici which had not been received at the year end and is included in debtors. 

During 2024 and the early part of 2025 the Foundation's running costs, principally the manager's salary, were funded by a loan from GC Mavel Ltd. Following receipt of the grant income, the majority of this loan was repaid in October 2025. 

## **Reserves policy** 

The trustees aim to hold free reserves equivalent to at least six months of core running costs, to allow the Foundation to meet its commitments and continue its activities should grant income fluctuate. Reserves above this level will be applied to the charity's objectives through grants and educational activities. At 31 December 2025 free reserves were £228,548, which the trustees intend to apply to planned charitable activities in 2026. 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

## **Governing document** 

1 



The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. 

## **Incorporation** 

The charitable company was incorporated on 4 June 2019 and commenced trading on 1 May 2024. 

## **REFERENCE AND ADMINISTRATIVE DETAILS** 

## **Registered Company number** 

CE017714 (England and Wales) 

## **Registered Charity number** 

1183723 

## **Registered office** 

70/2 Old Brompton Road London SW7 3DQ 

**Trustees** 

G Cotter P M Volterrani P O Chioncel P A J Coats Prof. G M C Rosano Prof. F Pinto (appointed 18.3.26) 

## **Independent Examiner** 

K D N De Silva Centora James Limited Jury Farm Ripley Lane West Horsley KT24 6JT 

## **SMALL COMPANY PROVISIONS** 

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. 

Approved by order of the board of trustees on ............................................. and signed on its behalf by: 

giuseppe rosano (Oct 29, 2026 16:35:19 GMT) {{sig1_es_:signer1:signature:dimension(width=80mm, height=15mm)}} ~~..............~~ ................................................................ 

Prof. G M C Rosano - Trustee 

2 



## **HEART SUCCESS FOUNDATION INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF HEART SUCCESS FOUNDATION** 

## **Independent examiner’s report to the trustees of Heart Success Foundation** 

I report to the charity Trustees on my examination of the accounts of Heart Success Foundation (the Trust) for the year ended 31 December 2025 which consists of the statement of financial activities, balance sheet and the related notes 

## **Responsibilities and basis of report** 

As the trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act') 

I report in respect of my examination of the Trust's accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

## **Independent Examiner's Statement** 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination which gives me cause to believe that in any material respect: 

1. the accounting records were not kept in accordance with section 130 of the Charities Act; or 

2. the accounts do not accord with the accounting records; or 

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair’ view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

.............................................................................. 

K D N De Silva, ACCA Association of Chartered Certified Accountants 

Centora James Limited Jury Farm Ripley Lane West Horsley KT24 6JT 

Date: ............................................. 

3 



## **HEART SUCCESS FOUNDATION STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**Notes**<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>2<br>Other income<br>3<br>**Total**<br>**EXPENDITURE ON**<br>Raising funds<br>Charitable activities<br>4<br>Other<br>**Total**<br>**NET INCOME/(EXPENDITURE)**<br>**RECONCILIATION OF FUNDS**<br>Total funds brought forward<br>**TOTAL FUNDS CARRIED FORWARD**|**2025**<br>**2024**<br>**Unrestricted**<br>**Total**<br>**fund**<br>**funds**<br>**£**<br>**£**<br> <br>277,503<br>6,100<br> <br>7,250<br>-|
|---|---|
||**284,753**<br>**6,100**<br>-<br>2,486<br> <br>51,814<br>-<br>-<br>8,005|
||**51,814**<br>**10,491**|
||**232,939**<br>**(4,391)**<br>(4,391)<br>-|
||**228,548**<br>**(4,391)**|



## **CONTINUING OPERATIONS** 

All income and expenditure has arisen from continuing activities. 

_The notes form part of these financial statements_ 

4 



## **HEART SUCCESS FOUNDATION BALANCE SHEET 31 DECEMBER 2025** 

|**Notes**<br>**CURRENT ASSETS**<br>Debtors<br>9<br>Cash at bank<br>**CREDITORS**<br>Amounts falling due within one year<br>10<br>**NET CURRENT ASSETS/(LIABILITIES)**<br>**TOTAL ASSETS LESS CURRENT LIABILITIES**<br>**NET ASSETS/(LIABILITIES)**<br>**FUNDS**<br>**11**<br>Unrestricted funds<br>**TOTAL FUNDS**|**2025**<br>**2024**<br>**Unrestricted**<br>**Total**<br>**fund**<br>**funds**<br>**£**<br>**£**<br> <br>85,449<br>6,000<br>155,786<br>100|
|---|---|
||241,235<br>6,100<br> <br>(12,687)<br>(10,491)|
||**228,548**<br>**(4,391)**|
||**228,548**<br>**(4,391)**|
||**228,548**<br>**(4,391)**|
||228,548<br>(4,391)|
||**228,548**<br>**(4,391)**|



The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025. 

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006. 

The trustees acknowledge their responsibilities for 

(a)  ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and 

(b)  preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. 

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. 

The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: 

giuseppe rosano (Oct 29, 2026 16:35:19 GMT) 

............................................. Prof. G M C Rosano - Trustee 

_The notes form part of these financial statements_ 

5 



**HEART SUCCESS FOUNDATION NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **1.    ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. 

## **Going concern** 

The trustees have assessed the charity's ability to continue as a going concern. Having regard to the level of unrestricted reserves held at the year end and the charity's planned activities, the trustees consider it appropriate to prepare the financial statements on a going concern basis. 

## **Income** 

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. Grants receivable are recognised when the charity becomes entitled to them. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

## **Grants payable** 

Grants payable are charged to the Statement of Financial Activities when the charity has made an unconditional commitment to the recipient and the recipient has been informed. 

## **Support costs** 

Support costs, which include staff, governance, travel and administrative costs, are allocated in full to charitable activities as this is the charity's only activity. 

## **Foreign currencies** 

Transactions in foreign currencies are translated into sterling at the average rate of exchange for December 2025 published by HM Revenue & Customs, which the trustees consider a reasonable approximation of the rates ruling during the period. Monetary assets and liabilities denominated in foreign currencies are retranslated at the HM Revenue & Customs monthly exchange rate in force at the balance sheet date. Exchange differences are recognised in the Statement of Financial Activities. 

## **Taxation** 

The charity is exempt from corporation tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

6 



**HEART SUCCESS FOUNDATION NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **Pension costs and other post-retirement benefits** 

The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. 

## **2.    DONATIONS AND LEGACIES** 

|Grants<br>Donations<br>Earned income<br>Grants received in the year comprised:<br>Servier Affaires Médicales<br>Institut La Conférence Hippocrate<br>BGP Products Operations GmbH<br>Bruno Farmaceutici<br>**THER INCOME**<br>Card cashback<br>Foreign exchange gains<br>**HARITABLE ACTIVITIES COSTS**<br>**Direct**<br>**costs**<br>**£**<br>Education and research in<br>cardiovascular medicine<br>9,954<br>9,954|Grants<br>Donations<br>Earned income<br>Grants received in the year comprised:<br>Servier Affaires Médicales<br>Institut La Conférence Hippocrate<br>BGP Products Operations GmbH<br>Bruno Farmaceutici<br>**THER INCOME**<br>Card cashback<br>Foreign exchange gains<br>**HARITABLE ACTIVITIES COSTS**<br>**Direct**<br>**costs**<br>**£**<br>Education and research in<br>cardiovascular medicine<br>9,954<br>9,954|**2025**<br>**2024**<br>**£**<br>**£**<br>277,503<br>-<br>-<br>100<br>-<br>6,000|
|---|---|---|
|||277,503<br>6,100|
|||**2025**<br>**2024**<br>**£**<br>**£**<br>93,881<br>-<br>76,811<br>-<br>30,000<br>-<br>76,811<br>-|
|||277,503<br>-|
|||**2025**<br>**2024**<br>**£**<br>**£**<br>37<br>-<br>7,213<br>-|
|||7,250<br>-|
|||**Support costs**<br>**(see note 6)**<br>**Totals**<br>**£**<br>**£**<br>41,860<br>51,814|
||9,954|41,860<br>51,814|



## **3.    OTHER INCOME** 

## **4.    CHARITABLE ACTIVITIES COSTS** 

Direct costs comprise grants payable of £9,810 (see note 5) and professional training of £144. 

## **5.    GRANTS PAYABLE** 

|**ANTS PAYABLE**|||
|---|---|---|
||**2025**|**2024**|
||**£**|**£**|
|Education and research in cardiovascular medicine|9,810|-|



Grants were paid to two individuals in support of educational projects on mineralocorticoid receptor antagonists (MRAs), including an educational project in Africa. No grants were made to institutions in the year. 

7 



## **HEART SUCCESS FOUNDATION** 

**NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **6.    SUPPORT COSTS** 

|Staff costs (see note 8)<br>Travel<br>Information technology<br>Governance - accountancy and independent examination<br>Bank charges|**2025**<br>**2024**<br>**£**<br>**£**<br>30,783<br>7,325<br>7,329<br>-<br>810<br>680<br>2,728<br>-<br>210<br>-|
|---|---|
||41,860<br>8,005|



In 2024 support costs were presented within "Other" expenditure in the Statement of Financial Activities. 

## **7.    TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024. 

## **Trustees' expenses** 

There were no trustees' expenses paid for the year ended 31 December 2025 nor for the year ended 31 December 2024. 

## **8.    STAFF COSTS** 

|**AFF COSTS**|||
|---|---|---|
||**2025**|**2024**|
||**£**|**£**|
|Wages and salaries|29,962|7,250|
|Other pension costs|821|75|
||30,783|7,325|
|The average monthly number of employees during the year was as follows:|||
||**2025**|**2024**|
|Administration|1|1|



The average monthly number of employees during the year was as follows: 

No employees received emoluments in excess of £60,000. 

## **9.    DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

|**BTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**||
|---|---|
|Trade debtors<br>**REDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Social security and other taxes<br>Other creditors<br>Wages payable<br>Loan from trustee<br>Accruals|**2025**<br>**2024**<br>**£**<br>**£**<br>85,449<br>6,000|
||**2025**<br>**2024**<br>**£**<br>**£**<br>3,896<br>1,149<br>1,817<br>176<br>2,000<br>2,000<br>3,774<br>7,166<br>1,200<br>-|
||12,687<br>10,491|



## **10.    CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

8 



## **HEART SUCCESS FOUNDATION NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **11.    MOVEMENT IN FUNDS** 

|**MOVEMENT IN FUNDS**||||
|---|---|---|---|
|||**Net**||
|||**movement**|**At**|
||**At 1.1.25**|**in funds**|**31.12.25**|
||**£**|**£**|**£**|
|**Unrestricted funds**||||
|General fund|(4,391)|232,939|228,548|
|**TOTAL FUNDS**|**(4,391)**|**232,939**|**228,548**|
|Net movement in funds, included in the above are as follows:||||
||**Incoming**|**Resources**|**Movement**|
||**resources**|**expended**|**in funds**|
||**£**|**£**|**£**|
|**Unrestricted funds**||||
|General fund|284,753|(51,814)|232,939|
|**TOTAL FUNDS**|**284,753**|**(51,814)**|**232,939**|
|**Comparatives for movement in funds**||||
|||**Net**||
|||**movement**|**At**|
||**At 1.1.24**|**in funds**|**31.12.24**|
||**£**|**£**|**£**|
|**Unrestricted funds**||||
|General fund|-|(4,391)|(4,391)|
|**TOTAL FUNDS**|**-**|**(4,391)**|**(4,391)**|



## **12.    RELATED PARTY DISCLOSURES** 

During 2024 and 2025 GC Mavel Ltd, a company of which a trustee of the charity is a director, paid the charity's staff and other running costs on its behalf by way of an interest-free loan with no fixed repayment terms. The movements on the loan during the year were as follows: 

|Balance at 1 January<br>Costs paid on behalf of the charity<br>Repaid by the charity<br>Balance at 31 December|**2025**<br>**2024**<br>**£**<br>**£**<br>7,166<br>-<br>20,000<br>7,166<br>(23,392)<br>-|
|---|---|
||3,774<br>7,166|



The balance is included within creditors as "Loan from trustee" (note 10). 

During the year Prof. G M C Rosano, a trustee, paid pension contributions of £1,680 to the National Employment Savings Trust on behalf of the charity, covering the contributions due for December 2024 to September 2025. The amount was unpaid at 31 December 2025 and is included within other creditors (note 10) (2024: £nil). 

9 



## **HEART SUCCESS FOUNDATION** 

**DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**INCOME AND ENDOWMENTS**<br>**Donations and legacies**<br>Grants<br>Donations<br>Earned income<br>**Other income**<br>Card cashback<br>Foreign exchange gains<br>**Total incoming resources**<br>**EXPENDITURE**<br>**Raising donations and legacies**<br>Website costs<br>**Charitable activities**<br>Grants to individuals<br>Training<br>**Support costs**<br>Management<br>Wages<br>Pensions<br>Travel<br>Bank charges<br>Information technology<br>IT software and consumables<br>Governance costs<br>Accountancy and independent examination<br>**Total resources expended**<br>**Net income/(expenditure)**|**2025**<br>**2024**<br>**£**<br>**£**<br>277,503<br>-<br>-<br>100<br>-<br>6,000|
|---|---|
||277,503<br>6,100<br>37<br>-<br>7,213<br>-|
||7,250<br>-|
||**284,753**<br>**6,100**<br>-<br>2,486<br>9,810<br>-<br>144<br>-|
||9,954<br>-<br>29,962<br>7,250<br>821<br>75<br>7,329<br>-<br>210<br>-|
||38,322<br>7,325<br>810<br>680<br>2,728<br>-|
||**51,814**<br>**10,491**|
||**232,939**<br>**(4,391)**|



_This page does not form part of the statutory financial statements_ 

10 

